Abeona Therapeutics (ABEO) Asset Utilization Ratio (2011 - 2026)

Abeona Therapeutics' Asset Utilization Ratio history runs 15 years deep, the most recent figure standing at 0.07 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio changed N/A year-over-year to 0.07; the TTM figure through Mar 2026 stood at 0.07 (changed N/A YoY), while the FY2025 annual figure was 0.04, changed N/A from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.07, up from 0.03 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.23 in Q2 2022, with the low at 0.0 in Q3 2025.
• The 5-year median for Asset Utilization Ratio is 0.05 (2023), against an average of 0.07.
• The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio slumped 88.17% in 2023, then jumped 177.5% in 2024.
• Abeona Therapeutics' Asset Utilization Ratio stood at 0.03 in 2022, then surged by 95.93% to 0.05 in 2023, then retreated by 6.3% to 0.05 in 2024, then slumped by 48.77% to 0.03 in 2025, then jumped by 169.31% to 0.07 in 2026.
• Business Quant data shows ABEO's Asset Utilization Ratio at 0.07 in Q1 2026, 0.03 in Q4 2025, and 0.0 in Q3 2025.